UBS lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $77 from $90 and keeps a Neutral rating on the shares post the earnings report. The firm sees a balanced risk/reward at current share levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro price target lowered to $85 from $95 at Wells Fargo
- Scotts Miracle-Gro price target lowered to $80 from $85 at JPMorgan
- Scotts Miracle-Gro Reports Strong Fiscal 2024 Results
- Scotts Miracle-Gro calls 2025 EBITDA guidance ‘conservative’
- Scotts Miracle-Gro sees 2025 EBITDA of $570M-$590M